Manager- Digital Analytics Regular, Full time CTS India Hyderabad (Office) Set 11, 2024 Analyst - Digital Analytics Regular, Full time CTS India Hyderabad (Office) Set 11, 2024 SSO Study Start-Up Team ...
Job Title Sort ascending Business Location Site Date Posted 高级医药代表 Regulär (Außendienst), Full time Innovative Medicines China Guangzhou (Guangdong Province) Sep 19, 2024 Business Data Migration ...
BPA Manager / Analyst Regular, Full time CTS Indien Hyderabad (Office) Sep 20, 2024 BPA Manager / Analyst Regular, Full time CTS Indien Hyderabad (Office) Sep 20, 2024 BPA Manager / Analyst Regelmatig ...
New Novartis data in relapsing MS reinforce benefits of Kesimpta® for first-line and switch patients
Nearly 90% of first-line Kesimpta patients had no disability progression independent of relapse activity (PIRA) for up to six years in an analysis of open-label ALITHIOS extension study 1 More than 80 ...
诺华 承 诺 与残障人士共事并 为 他 们 提供合理的便利 设 施。如果您由于健康状况或残障 在招聘 过 程的任何 环 节 需要合理便利 设 施 或者 为 了履行 职 位的基本 职 能 请发 送 电 子 邮 件 ...
Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4/6 inhibitor adjuvant therapy 1,2 Kisqali ® ...
Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4/6 inhibitor adjuvant therapy1,2 Kisqali® ...
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback